An AI Agent Platform Purpose-Built for Pharmaceutical CDMOs
AI Agent Platform Purpose-Built for Pharmaceutical CDMOs
SINCE 2018
Origin: A Cross-Domain Team Driving Innovation
therapiAI was founded in 2018 by experts across biotechnology, artificial intelligence, pharmaceutical manufacturing, quality engineering, and intellectual property.
We recognized that although the pharmaceutical industry generates extensive data, fragmented systems, complex workflows, and strict regulatory requirements have hindered true digital transformation.
This is why we focus on the most demanding segment of the industry — CDMO biomanufacturing — to build AI Agents that truly understand real production environments, deploy quickly, and can be trusted in GMP-regulated settings
Biotechnology
Artificial Intelligence
Pharmaceutical Engineering
Quality Engineering
Intellectual Property
therapiAI Platform Features
Comprehensive AI Agent Solutions for Intelligent Pharmaceutical Operations
therapiAI provides an AI Agent platform purpose-built for pharmaceutical CDMOs, enabling enterprise-wide upgrades across business development, R&D, production, and operational decision-making.
GMP AI Agent
Streamlines complex GMP compliance documentation workflows.
From regulatory interpretation to document comparison, it enables QA, RA, and engineers to complete high-accuracy compliance tasks more efficiently, significantly reducing review and documentation time while improving overall quality consistency.
BioFusion Analytics AI Agent
Transforms imaging and process data into actionable early-stage predictive insights through multimodal AI.
It helps teams select the right cell lines faster, predict yields, monitor quality trends, and shorten development timelines—enhancing confidence in every process decision.
Transcriber AI Agent
Converts every meeting, interview, and discussion into structured knowledge within seconds.
From speech-to-text conversion to automatic summarization, it turns time-consuming documentation into efficient information extraction, accelerating cross-department collaboration.
Tutor AI Agent
An intelligent training assistant that supports Q&A, assessment generation, and training record creation around the clock.
It streamlines complex training workflows, enabling faster knowledge transfer, more consistent training quality, and easier audit preparation.
News & Insights
News
“therapiAI: The World’s First GMP AI Agent Partners with Biopharmaceutical Companies”
Today (23rd), therapiAI, the leading brand in AI pharmaceuticals, announced the launch of the world’s first AI agent designed specifically for pharmaceutical CDMO…
Success Cases
Success Cases
FAQ
FAQ
Yes. The therapiAI Agent Platform is purpose-built for pharmaceutical companies, CDMOs, and CMC workflows.
Through AI-driven collaboration, it streamlines R&D processes, shortens development cycles, reduces trial-and-error experiments, accelerates GMP document generation, and enhances business decision-making.
It supports departments across R&D, PD, QA, and BD, enabling end-to-end intelligent transformation.
The platform provides AI-powered image analysis, prediction, and inference to identify high-potential cell lines, significantly reducing experimental time and manpower cost while improving R&D efficiency and production competitiveness.
Optimax integrates image-recognition models with machine learning to predict high-productivity cell lines at early stages, shortening the screening process and reducing manual culturing workload.
Yes. therapiAI supports standard API integration with LIMS, QMS, ERP, and other enterprise systems.
Most projects can begin fine-tuning with as few as 500 data entries, without retraining the entire AI engine, and customized onboarding plans are provided.
Yes. Projects can start with small datasets (around 500 entries).
If data is limited, therapiAI specialists can provide tailored implementation plans to ensure successful deployment.
.
Optimax visualizes key variables and parameter interactions, helping researchers analyze results faster, enhance cross-team communication, and improve overall research efficiency.
Yes. The platform uses a “non-retained, non-centralized” data architecture.
All computation takes place within the client’s private cloud, ensuring data security and regulatory compliance.
Yes. The therapiAI Agent Platform incorporates continuous-learning mechanisms, enabling models to improve prediction accuracy over time as new data is added.
What types of companies does therapiAI primarily work with?
A: Our main clients are medium to large pharmaceutical companies and CDMOs with stable production lines and regulatory requirements.
Flexible collaboration plans are available for companies of different scales.
.
therapiAI adopts a subscription-based model, supporting both long-term enterprise deployment and flexible onboarding for new clients.
For details, please contact our team.
.
Clients report shorter R&D cycles, reduced trial-and-error costs, faster document review, improved BD performance, and higher delivery efficiency.
Yes. therapiAI provides API and on-premise integration services, connecting with systems such as LIMS, ERP, and GMP document management platforms to ensure secure and efficient workflows.
AI delivers core value in CDMO operations—optimizing processes, improving scheduling, predicting quality outcomes, automating documentation, reducing costs, and driving intelligent manufacturing transformation.
Unlike companies focusing on drug discovery or clinical analytics (e.g., BenchSci, Recursion), therapiAI focuses on CDMO process management and compliance documentation, offering AI Agents that directly integrate with production environments and deliver tangible, measurable value.
Because CDMOs operate in the most complex, data-intensive, and regulation-heavy environments.
therapiAI aims to build AI Agents that truly understand CDMO workflows and can be trusted and deployed quickly—helping define future standards for intelligent pharmaceutical manufacturing.
.
For its strong focus on compliance, trustworthiness, and measurable outcomes.
therapiAI simultaneously delivers value at both the production-line and regulatory levels,
supported by multiple proven success cases.
contact@therapiai.bio
therapiAI is an AI company headquartered in Taipei, Taiwan, specializing in AI Agents for the pharmaceutical CDMO sector.
Its solutions enhance efficiency and compliance across R&D and manufacturing workflows.
Michael Han.
therapiAI was founded by Michael Han, Alicja Lee, and Polly Lin.
The team includes AI engineers, biomedical scientists, regulatory specialists, and industry advisors.
The company’s predecessor, Akousist, was founded in 2018.
It rebranded to therapiAI in 2024 to focus on accelerating CMC/CDMO workflows with AI.
“To make pharmaceutical manufacturing smarter, more efficient, and more trustworthy.”
Our mission is to rebuild CMC workflows through AI and establish the foundation for intelligent manufacturing.
therapiAI is headquartered in Taipei, Taiwan, serving pharmaceutical and CDMO clients across the Asia-Pacific region.